Presented by Dr. Amber Cann
This webinar presents information on the pharmacology, receptor activity, and clinical effects of major psychedelic compounds, including psilocybin, DMT, MDMA, ketamine, and mescaline. It includes the clinical evidence and ethical considerations surrounding psychedelic-assisted therapy in conditions such as depression, PTSD, and addiction, as well as ways clinicians can support culturally respectful and equitable research practices.
File Type:
www